Impressively, HSP70+ CD8+ T cells were drastically reduced upon in CX-5461 treatment, underscoring the pivotal role of hyperactivated ribosome activity in sustaining the number of these non-tumour cells within the TME (Fig. 3h). The gene discussed is CD8A; the disease is neoplasm.